PRF Technologies (PRFX) Cash & Equivalents (2019 - 2025)
PRF Technologies (PRFX) recorded quarterly Cash & Equivalents of $3.1 million in Q4 2025, down 10.18% on a QoQ basis from $3.5 million in Q2 2025, and down 26.66% year-over-year from $4.3 million in Q4 2024.
PRF Technologies (PRFX) Cash & Equivalents (2019 - 2025) Analysis & Trends
PRF Technologies has disclosed Cash & Equivalents across 7 years of filings, most recently posting $3.1 million for Q4 2025.
- Quarterly Cash & Equivalents fell 26.66% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (down 26.66% YoY) and the FY2025 annual result came in at $3.1 million, down 26.66% from the prior year.
- Cash & Equivalents declined to $3.1 million in Q4 2025, from $3.5 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $19.4 million in Q1 2021 and troughed at $10000.0 in Q4 2023.
- A 5-year average of $8.9 million and a median of $6.9 million in 2022 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents tumbled 99.76% — and 2024, when it soared 42510.0%.
- Tracing PRFX's Cash & Equivalents over 5 years: stood at $16.5 million in 2021, then slumped by 75.23% to $4.1 million in 2022, then slumped by 99.76% to $10000.0 in 2023, then surged by 42510.0% to $4.3 million in 2024, then retreated by 26.66% to $3.1 million in 2025.
- Business Quant data shows PRFX's Cash & Equivalents at $3.1 million in Q4 2025, $3.5 million in Q2 2025, and $4.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 266.50 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 47.17 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 222.79 Mn |
| 10 | PRF Technologies | 894,202.74 | -2.50 Mn | - | 3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.13 Mn |
| Jun 30, 2025 | 3.48 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Jun 30, 2024 | 2.78 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 7.56 Mn |
| Jun 30, 2023 | 5.14 Mn |
| Mar 31, 2023 | 8.15 Mn |
| Dec 31, 2022 | 4.10 Mn |
| Sep 30, 2022 | 6.92 Mn |
| Jun 30, 2022 | 13.85 Mn |
| Mar 31, 2022 | 15.42 Mn |
| Dec 31, 2021 | 16.54 Mn |
| Sep 30, 2021 | 18.34 Mn |
| Jun 30, 2021 | 17.79 Mn |
| Mar 31, 2021 | 19.42 Mn |
| Dec 31, 2020 | 15.68 Mn |
| Sep 30, 2020 | 17.72 Mn |
| Jun 30, 2020 | 544,000.00 |